-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Underperform on Sarepta Therapeuticsto Underperform

Benzinga·09/28/2026 10:14:44
Listen to the news
Needham analyst Gil Blum reiterates Sarepta Therapeutics (NASDAQ:SRPT) from Underperform to Underperform.